Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/26884372/ below:

Ovarian cancer survivors' quality of life: a systematic review

Review

Affiliations

• ¹ U1086 INSERM, Cancers and Preventions, Center François Baclesse, 3 Avenue du General Harris, 14076, Caen, France. d.ahmed-lecheheb@mail.baclesse.fr.
• ² U1086 INSERM, Cancers and Preventions, Center François Baclesse, 3 Avenue du General Harris, 14076, Caen, France.
• ³ Medical Oncology Department-Clinical Research Department, Center François Baclesse-CHU Côte de nacre, Caen, France.

• PMID: 26884372
• DOI: 10.1007/s11764-016-0525-8

Item in Clipboard

Review

D Ahmed-Lecheheb et al. J Cancer Surviv. 2016 Oct.

• ¹ U1086 INSERM, Cancers and Preventions, Center François Baclesse, 3 Avenue du General Harris, 14076, Caen, France. d.ahmed-lecheheb@mail.baclesse.fr.
• ² U1086 INSERM, Cancers and Preventions, Center François Baclesse, 3 Avenue du General Harris, 14076, Caen, France.
• ³ Medical Oncology Department-Clinical Research Department, Center François Baclesse-CHU Côte de nacre, Caen, France.

• PMID: 26884372
• DOI: 10.1007/s11764-016-0525-8

Item in Clipboard

Purpose: The assessment of quality of life (QOL) among ovarian cancer (OC) patients has mainly focused on the acute phase of treatment. This systematic review examines studies measuring QOL in patients who survived OC after treatment and synthesizes results in order to assess QOL and patient-reported outcome (PRO) data at long-term follow-up.

Methods: Articles published in English between 1990 to November 2014 were identified with the databases MEDLINE and PubMed, using the specific keywords "OC survivors" combined with the terms, "QOL," "health-related QOL," and "PROs." Data were reviewed for design, time since end of treatment, measurement tools, and outcomes (categorized in three topics: global QOL compared to controls, treatment sequelae, and intervention strategies).

Results: The initial search strategy provided 148 articles of which 31 were considered eligible. Most studies focused on epithelial OC, and only a few studies investigated survivors of ovarian germ cell tumor. More than 60 instruments of QOL measures were used in the corpus. Despite the persistence of psychological and physical symptoms, treatment sequelae, sexual problems, and fear of recurrence in some survivors, most studies demonstrated that OC survivors generally have good QOL compared to healthy women. Studies proposing interventions are lacking.

Conclusions and implications for cancer survivor: OC survivors experience a wide range of sequelae that may persist for a long time and negatively impact QOL. Further large-scale research is needed to fully understand problems that have significant effects on QOL, in order to develop interventions and treatments suitable for women at need.

Keywords: Ovarian cancer; Patient-reported outcomes; Quality of life; Survivors.

PubMed Disclaimer

• Quality of life among long-term survivors of advanced stage ovarian cancer: A cross-sectional approach.

  Lutgendorf SK, Shinn E, Carter J, Leighton S, Baggerly K, Guindani M, Fellman B, Matzo M, Slavich GM, Goodman MT, Tew W, Lester J, Moore KM, Karlan BY, Levine DA, Sood AK. Lutgendorf SK, et al. Gynecol Oncol. 2017 Jul;146(1):101-108. doi: 10.1016/j.ygyno.2017.05.008. Epub 2017 May 17. Gynecol Oncol. 2017. PMID: 28527672 Free PMC article.

• Sexual activity and quality of life in patients after treatment for breast and ovarian cancer.

  Mayer S, Iborra S, Grimm D, Steinsiek L, Mahner S, Bossart M, Woelber L, Voss PJ, Gitsch G, Hasenburg A. Mayer S, et al. Arch Gynecol Obstet. 2019 Jan;299(1):191-201. doi: 10.1007/s00404-018-4922-2. Epub 2018 Nov 1. Arch Gynecol Obstet. 2019. PMID: 30386993

• Determinants of quality of life in ovarian cancer survivors: a pilot study.

  Teng FF, Kalloger SE, Brotto L, McAlpine JN. Teng FF, et al. J Obstet Gynaecol Can. 2014 Aug;36(8):708-715. doi: 10.1016/S1701-2163(15)30513-2. J Obstet Gynaecol Can. 2014. PMID: 25222166

• Survivorship issues in ovarian cancer: a review.

  Lockwood-Rayermann S. Lockwood-Rayermann S. Oncol Nurs Forum. 2006 May 3;33(3):553-62. doi: 10.1188/06.ONF.553-562. Oncol Nurs Forum. 2006. PMID: 16676012 Review.

• Long-term quality of life in gynecological cancer survivors.

  Gonçalves V. Gonçalves V. Curr Opin Obstet Gynecol. 2010 Feb;22(1):30-5. doi: 10.1097/GCO.0b013e328332e626. Curr Opin Obstet Gynecol. 2010. PMID: 19809316 Review.

• A meta-review of qualitative research on adult cancer survivors: current strengths and evidence gaps.

  Laidsaar-Powell R, Konings S, Rankin N, Koczwara B, Kemp E, Mazariego C, Butow P. Laidsaar-Powell R, et al. J Cancer Surviv. 2019 Dec;13(6):852-889. doi: 10.1007/s11764-019-00803-8. Epub 2019 Nov 19. J Cancer Surviv. 2019. PMID: 31745818

• Tanshinone IIA induces apoptosis of ovarian cancer cells in vitro and in vivo through attenuation of PI3K/AKT/JNK signaling pathways.

  Zhang X, Zhou Y, Gu YE. Zhang X, et al. Oncol Lett. 2019 Feb;17(2):1896-1902. doi: 10.3892/ol.2018.9744. Epub 2018 Nov 21. Oncol Lett. 2019. PMID: 30675253 Free PMC article.

• A Study on the Psychological Factors Affecting the Quality of Life Among Ovarian Cancer Patients in China.

  Gu ZH, Qiu T, Yang SH, Tian FQ, Wu H. Gu ZH, et al. Cancer Manag Res. 2020 Feb 7;12:905-912. doi: 10.2147/CMAR.S239975. eCollection 2020. Cancer Manag Res. 2020. PMID: 32104072 Free PMC article.

• Proactive use of PROMs in ovarian cancer survivors: a systematic review.

  Kargo AS, Coulter A, Jensen PT, Steffensen KD. Kargo AS, et al. J Ovarian Res. 2019 Jul 15;12(1):63. doi: 10.1186/s13048-019-0538-9. J Ovarian Res. 2019. PMID: 31307510 Free PMC article. Review.

• Matrine inhibits ovarian cancer cell viability and promotes apoptosis by regulating the ERK/JNK signaling pathway via p38MAPK. Liang X, Ju J. Liang X, et al. Oncol Rep. 2021 May;45(5):82. doi: 10.3892/or.2021.8033. Epub 2021 Mar 31. Oncol Rep. 2021. PMID: 33786627 Free PMC article. Retracted.

1. 1. Oncol Nurs Forum. 2006 May 03;33(3):553-62 - PubMed
2. 1. BMC Cancer. 2009 Jan 02;9:2 - PubMed
3. 1. Obstet Gynecol. 2006 May;107(5):1075-85 - PubMed
4. 1. Gynecol Oncol. 2012 Apr;125(1):59-64 - PubMed
5. 1. Int J Gynaecol Obstet. 2006 Nov;95 Suppl 1:S247-57 - PubMed

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3